Abstract
Objective: To find the incidence of neonatal sepsis, microorganisms involved and their antibiotic sensitivityamong neonates admitted with neonatal sepsis during the study period.Study Design: Prospective observational study.Place and Duration of Study: The study was carried out at neonatal intensive care unit (NICU) of combinedmilitary Hospital (CMH), Kharian, Pakistan from January 2019 to December 2020.Materials and Methods: After getting permission from Ethical Review Board of hospital, all the neonates whowere admitted in neonatal intensive care unit (NICU) of hospital with neonatal sepsis were included in subjectstudy. All the neonates with fever, irritability, difficulty in feeding, respiratory distress, fits, bulging fontanels,jaundice, bleeding etc. were suspected as case of "Neonatal sepsis". Venous blood sample of neonates wasdrawn under aseptic technique and collected in sterile BacT/ALERT (PF) blood collecting culture bottles andsent to laboratory immediately for culture, sensitivity procedure and reporting.Results: A total of 4892 neonates were admitted in neonatal intensive care unit from January 2019 toDecember 2020. Out of these, 342 neonates were clinically diagnosed as cases of neonatal sepsis. Incidence ofneonatal sepsis was 6.99%, comprising 185 males (54.1%) and 157 females (45.9%). The age range was from 2days to 88 days with a mean age 35.47+23.40 days. Staphylococcus aureus was found to be the most commonlyinfectious microorganism (33.9%) followed by Candida species (18.5%), Klebsiella pneumoniae (14.5%) andCoagulase negative Staphylococci (12.3%). Non-fermenting Gram negative bacteria were found to be infecting26 (11.5%) out of the total positive cases (Acinetobacter baumannii complex 8.4%, Stenotrophomonasmaltophilia 3.1% and Pseudomonas aeruginosa 2.6%).Conclusion: Staphylococcus aureus was the most prevalent organism found to be responsible for neonatalsepsis with majority being resistant to Methicillin. Methicillin-resistant Staphylococcus aureus (MRSA) is a100% percent sensitive to vancomycin and Teicoplanin. On the other hand, Gram Negative organisms haveshown promising sensitivity to Colistin.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.